Passage Bio, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -58.2% | -58.2% | -52.2% |
| FY2022 | -67.6% | -67.6% | -55.9% |
| FY2023 | -91.7% | -91.7% | -67.8% |
| FY2024 | -105.7% | -105.7% | -63.2% |
| FY2025 | -242.7% | -242.7% | -73.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -58.2% | -58.2% | -52.2% |
| FY2022 | -67.6% | -67.6% | -55.9% |
| FY2023 | -91.7% | -91.7% | -67.8% |
| FY2024 | -105.7% | -105.7% | -63.2% |
| FY2025 | -242.7% | -242.7% | -73.1% |